Patent · US Active

Protein stabilization formulations

US7956028B2 · kind B2 · utility

17Cited by
66References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 4, 2007
Grant dateJun 7, 2011
Priority date
Expiry dateMay 22, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to stabilizing Bone Morphogenetic Protein in various lyophilized formulations and compositions. The present invention comprises formulations primarily including trehalose as an excipient for lyophilized compositions and their subsequent storage and reconstitution, and can also optionally include other excipients, including buffers and surfactants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.